Sort   by:  
 Page size 
UnknownPatient-reported outcome results from the open-label phase III AURELIA trial evaluating bevacizumab-containing therapy for platinum-resistant ovarian cancer.
Not available
S-EPMC4876313 | biostudies-literature
UnknownOlaparib as maintenance treatment for patients with platinum-sensitive relapsed ovarian cancer.
Not available
S-EPMC6535754 | biostudies-literature
UnknownRandomized Phase II Trial of Seribantumab in Combination With Paclitaxel in Patients With Advanced Platinum-Resistant or -Refractory Ovarian Cancer.
Not available
S-EPMC5562430 | biostudies-literature
UnknownLeft Ventricular Ejection Fraction in Patients With Ovarian Cancer Treated With Avelumab, Pegylated Liposomal Doxorubicin, or Both.
Not available
S-EPMC10546816 | biostudies-literature
UnknownPrediction of tumour response induced by chemotherapy using modelling of CA-125 kinetics in recurrent ovarian cancer patients.
Not available
S-EPMC3960627 | biostudies-literature
UnknownAbagovomab as maintenance therapy in patients with epithelial ovarian cancer: a phase III trial of the AGO OVAR, COGI, GINECO, and GEICO--the MIMOSA study.
Not available
S-EPMC5795662 | biostudies-literature
UnknownQuality of life predicts overall survival in women with platinum-resistant ovarian cancer: an AURELIA substudy.
Not available
S-EPMC6410892 | biostudies-literature
UnknownEndothelial protein C receptor expressed by ovarian cancer cells as a possible biomarker of cancer onset.
Not available
S-EPMC3582880 | biostudies-literature
UnknownTelomere length is a prognostic biomarker in elderly advanced ovarian cancer patients: a multicenter GINECO study.
Not available
S-EPMC4712332 | biostudies-literature
UnknownPredicting tumor response and outcome of second-look surgery with 18F-FDG PET/CT: insights from the GINECO CHIVA phase II trial of neoadjuvant chemotherapy plus nintedanib in stage IIIc-IV FIGO ovarian cancer.
Not available
S-EPMC8113167 | biostudies-literature
Sort   by:  
 Page size